Kasikorn Securities forecasts that KLINIQ will report a normal profit of 115 million baht for the second quarter of 2026, up 29% from the same period last year, and expects an interim dividend payment for the first half of 2026 of 0.80 baht per share, an increase of 14% from the previous year. As a result, major shareholders Mr. Sathaporn Ngamruangphong and Mr. Paiboon Sereewiwattana will receive combined dividends of more than 15.25 million baht. Mr. Sathaporn holds 4,330,300 shares, representing a 1.97% stake, and will receive a pre-tax dividend of approximately 3.46 million baht, while Mr. Paiboon holds 14,737,882 shares, representing a 6.70% stake, and will receive a pre-tax dividend of approximately 11.79 million baht.
The Klinique Med Clinic PCLKLINIQ expects Q2 2026 profit up 29% and interim dividend of 0.80 baht per share, boosting shareholder returns.